Literature DB >> 23474232

Vaccine design: emerging concepts and renewed optimism.

Sebastian K Grimm1, Margaret E Ackerman.   

Abstract

Arguably, vaccination represents the single most effective medical intervention ever developed. Yet, vaccines have failed to provide any or adequate protection against some of the most significant global diseases. The pathogens responsible for these vaccine-recalcitrant diseases have properties that allow them to evade immune surveillance and misdirect or eliminate the immune response. However, genomic and systems biology tools, novel adjuvants and delivery systems, and refined molecular insight into protective immunity have started to redefine the landscape, and results from recent efficacy trials of HIV and malaria vaccines have instilled hope that another golden age of vaccines may be on the horizon.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23474232      PMCID: PMC3696422          DOI: 10.1016/j.copbio.2013.02.015

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  86 in total

1.  Probing structural changes of proteins incorporated into water-in-oil emulsions.

Authors:  Lene Jorgensen; Marco Van de Weert; Charlotte Vermehren; Simon Bjerregaard; Sven Frokjaer
Journal:  J Pharm Sci       Date:  2004-07       Impact factor: 3.534

2.  Reorienting our view of particle-based adjuvants for subunit vaccines.

Authors:  Steven R Little
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

3.  Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels.

Authors:  Grazia Galli; Duccio Medini; Erica Borgogni; Luisanna Zedda; Monia Bardelli; Carmine Malzone; Sandra Nuti; Simona Tavarini; Chiara Sammicheli; Anne K Hilbert; Volker Brauer; Angelika Banzhoff; Rino Rappuoli; Giuseppe Del Giudice; Flora Castellino
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

4.  Structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections.

Authors:  Annalisa Nuccitelli; Roberta Cozzi; Louise J Gourlay; Danilo Donnarumma; Francesca Necchi; Nathalie Norais; John L Telford; Rino Rappuoli; Martino Bolognesi; Domenico Maione; Guido Grandi; C Daniela Rinaudo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-18       Impact factor: 11.205

5.  Identification of a universal Group B streptococcus vaccine by multiple genome screen.

Authors:  Domenico Maione; Immaculada Margarit; Cira D Rinaudo; Vega Masignani; Marirosa Mora; Maria Scarselli; Hervé Tettelin; Cecilia Brettoni; Emilia T Iacobini; Roberto Rosini; Nunzio D'Agostino; Lisa Miorin; Scilla Buccato; Massimo Mariani; Giuliano Galli; Renzo Nogarotto; Vincenzo Nardi-Dei; Vincenzo Nardi Dei; Filipo Vegni; Claire Fraser; Giuseppe Mancuso; Giuseppe Teti; Lawrence C Madoff; Lawrence C Paoletti; Rino Rappuoli; Dennis L Kasper; John L Telford; Guido Grandi
Journal:  Science       Date:  2005-07-01       Impact factor: 47.728

6.  HIV-1 vaccines and adaptive trial designs.

Authors:  Lawrence Corey; Gary J Nabel; Carl Dieffenbach; Peter Gilbert; Barton F Haynes; Margaret Johnston; James Kublin; H Clifford Lane; Giuseppe Pantaleo; Louis J Picker; Anthony S Fauci
Journal:  Sci Transl Med       Date:  2011-04-20       Impact factor: 17.956

7.  Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens.

Authors:  Sampa Santra; Mark Muldoon; Sydeaka Watson; Adam Buzby; Harikrishnan Balachandran; Kevin R Carlson; Linh Mach; Wing-Pui Kong; Krisha McKee; Zhi-Yong Yang; Srinivas S Rao; John R Mascola; Gary J Nabel; Bette T Korber; Norman L Letvin
Journal:  Virology       Date:  2012-04-21       Impact factor: 3.616

8.  A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination.

Authors:  Peter T Beernink; Jutamas Shaughnessy; Emily M Braga; Qin Liu; Peter A Rice; Sanjay Ram; Dan M Granoff
Journal:  J Immunol       Date:  2011-02-16       Impact factor: 5.422

9.  Adjuvant solution for pandemic influenza vaccine production.

Authors:  Christopher H Clegg; Richard Roque; Neal Van Hoeven; Lucy Perrone; Susan L Baldwin; Joseph A Rininger; Richard A Bowen; Steven G Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

10.  Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.

Authors:  Morgane Rolland; Paul T Edlefsen; Brendan B Larsen; Sodsai Tovanabutra; Eric Sanders-Buell; Tomer Hertz; Allan C deCamp; Chris Carrico; Sergey Menis; Craig A Magaret; Hasan Ahmed; Michal Juraska; Lennie Chen; Philip Konopa; Snehal Nariya; Julia N Stoddard; Kim Wong; Hong Zhao; Wenjie Deng; Brandon S Maust; Meera Bose; Shana Howell; Adam Bates; Michelle Lazzaro; Annemarie O'Sullivan; Esther Lei; Andrea Bradfield; Grace Ibitamuno; Vatcharain Assawadarachai; Robert J O'Connell; Mark S deSouza; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Merlin L Robb; Jason S McLellan; Ivelin Georgiev; Peter D Kwong; Jonathan M Carlson; Nelson L Michael; William R Schief; Peter B Gilbert; James I Mullins; Jerome H Kim
Journal:  Nature       Date:  2012-09-10       Impact factor: 49.962

View more
  15 in total

1.  Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24.

Authors:  Puneet K Gupta; Paushali Mukherjee; Shikha Dhawan; Alok K Pandey; Suman Mazumdar; Deepak Gaur; S K Jain; Virander S Chauhan
Journal:  Clin Vaccine Immunol       Date:  2014-04-30

2.  Aluminum (Oxy)Hydroxide Nanosticks Synthesized in Bicontinuous Reverse Microemulsion Have Potent Vaccine Adjuvant Activity.

Authors:  Xu Li; Stephanie Hufnagel; Haiyue Xu; Solange A Valdes; Sachin G Thakkar; Zhengrong Cui; Hugo Celio
Journal:  ACS Appl Mater Interfaces       Date:  2017-06-29       Impact factor: 9.229

Review 3.  Biomimetic Nanotechnology toward Personalized Vaccines.

Authors:  Jiarong Zhou; Ashley V Kroll; Maya Holay; Ronnie H Fang; Liangfang Zhang
Journal:  Adv Mater       Date:  2019-06-17       Impact factor: 30.849

Review 4.  Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection.

Authors:  Cynthia A Derdeyn; Penny L Moore; Lynn Morris
Journal:  Curr Opin HIV AIDS       Date:  2014-05       Impact factor: 4.283

5.  Directed evolution of a yeast-displayed HIV-1 SOSIP gp140 spike protein toward improved expression and affinity for conformational antibodies.

Authors:  Sebastian K Grimm; Michael B Battles; Margaret E Ackerman
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

Review 6.  Metabolomics in the fight against malaria.

Authors:  Jorge L Salinas; Jessica C Kissinger; Dean P Jones; Mary R Galinski
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-08       Impact factor: 2.743

7.  Coevolutionary Analysis Identifies Protein-Protein Interaction Sites between HIV-1 Reverse Transcriptase and Integrase.

Authors:  Madara Hetti Arachchilage; Helen Piontkivska
Journal:  Virus Evol       Date:  2016-02-23

Review 8.  Systems Biology-Based Platforms to Accelerate Research of Emerging Infectious Diseases.

Authors:  Soo Jin Oh; Young Ki Choi; Ok Sarah Shin
Journal:  Yonsei Med J       Date:  2018-03       Impact factor: 2.759

Review 9.  Ancient oncogenesis, infection and human evolution.

Authors:  Riaan F Rifkin; Marnie Potgieter; Jean-Baptiste Ramond; Don A Cowan
Journal:  Evol Appl       Date:  2017-07-11       Impact factor: 5.183

10.  Putative virulence factors of Corynebacterium pseudotuberculosis FRC41: vaccine potential and protein expression.

Authors:  Karina T O Santana-Jorge; Túlio M Santos; Natayme R Tartaglia; Edgar L Aguiar; Renata F S Souza; Ricardo B Mariutti; Raphael J Eberle; Raghuvir K Arni; Ricardo W Portela; Roberto Meyer; Vasco Azevedo
Journal:  Microb Cell Fact       Date:  2016-05-16       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.